<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1748501</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2026.1748501</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Diminished fibrotic encapsulation and comparable physicochemical properties of poly (styrene-<italic>b</italic>-isobutylene-<italic>b</italic>-styrene) support its use as a biomaterial alternative to silicone implants</article-title>
<alt-title alt-title-type="left-running-head">Kalashnikov et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2026.1748501">10.3389/fbioe.2026.1748501</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kalashnikov</surname>
<given-names>Nikita</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3284091"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinchuk</surname>
<given-names>Leonard</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3289567"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Vorstenbosch</surname>
<given-names>Joshua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1835790"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Division of Surgical and Interventional Sciences, Department of Surgery, McGill University</institution>, <city>Montreal</city>, <state>QC</state>, <country country="CA">Canada</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Research Institute of the McGill University Health Centre</institution>, <city>Montreal</city>, <state>QC</state>, <country country="CA">Canada</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Faculty of Medicine and Health Sciences, McGill University</institution>, <city>Montreal</city>, <state>QC</state>, <country country="CA">Canada</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Innovia, LLC</institution>, <city>Miami</city>, <state>FL</state>, <country country="US">United States</country>
</aff>
<aff id="aff5">
<label>5</label>
<institution>Department of Biomedical Engineering, University of Miami</institution>, <city>Miami</city>, <state>FL</state>, <country country="US">United States</country>
</aff>
<aff id="aff6">
<label>6</label>
<institution>Division of Plastic and Reconstructive Surgery, Department of Surgery, McGill University Health Centre</institution>, <city>Montreal</city>, <state>QC</state>, <country country="CA">Canada</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Nikita Kalashnikov, <email xlink:href="mailto:nikita.kalashnikov@mail.mcgill.ca">nikita.kalashnikov@mail.mcgill.ca</email>; Joshua Vorstenbosch, <email xlink:href="mailto:joshua.vorstenbosch@mcgill.ca">joshua.vorstenbosch@mcgill.ca</email>
</corresp>
<fn fn-type="other" id="fn001">
<label>&#x2020;</label>
<p>ORCID: Nikita Kalashnikov, <uri xlink:href="https://orcid.org/0000-0001-9944-9542">orcid.org/0000-0001-9944-9542</uri>; Joshua Vorstenbosch, <uri xlink:href="https://orcid.org/0000-0001-8548-6625">orcid.org/0000-0001-8548-6625</uri>
</p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-26">
<day>26</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>14</volume>
<elocation-id>1748501</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Kalashnikov, Pinchuk and Vorstenbosch.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Kalashnikov, Pinchuk and Vorstenbosch</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-26">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Silicone &#x2013; namely polydimethylsiloxane (PDMS) &#x2013; is a widely recognized elastomeric biomaterial commonly used in implantable medical devices such as breast implants, cardiac pacemakers and drug delivery devices. Despite its widespread use, PDMS can elicit a strong foreign body response with fibrous encapsulation that leads to discomfort, pain and implantable device failure in approximately 10% of cases. Poly (styrene-<italic>block</italic>-isobutylene-<italic>block</italic>-styrene) (SIBS) is a thermoplastic elastomer used clinically as a drug-eluting coating for coronary stents and experimentally in ocular drainage devices. Although SIBS has demonstrated excellent biocompatibility in these applications, the foreign body response it elicits has not yet been extensively studied in more inflammation-prone anatomic sites such as skin rich in macrophages and fibroblasts. Here, we characterize the physicochemical properties of SIBS, examine its effect on macrophage-fibroblast interactions and evaluate its biocompatibility by implanting it subcutaneously in mice to ultimately assess its viability as a potential alternative to PDMS. We establish that both materials have comparable physicochemical properties, demonstrate that fibroblasts adopt a less contractile pro-inflammatory phenotype when exposed to SIBS-macrophage conditioned media and show reduced fibrotic encapsulation around SIBS implants in mice. These results suggest that SIBS could potentially be a favorable biomaterial alternative to silicone in clinical applications.</p>
</abstract>
<kwd-group>
<kwd>foreign body response</kwd>
<kwd>PDMS</kwd>
<kwd>poly (styrene-block-isobutylene-block-styrene)</kwd>
<kwd>SIBS</kwd>
<kwd>silicone</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by research start-up funds from the Montreal General Hospital Foundation and the McGill University Division of Plastic Surgery as well as the Chercheurs-boursiers cliniciens program of the Fonds de recherche du Qu&#xe9;bec (Sant&#xe9;).</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="98"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Biomaterials</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Implantable medical devices reduce mortality and improve quality of life: breast implants restore the form of the breast, cardiac pacemakers modulate the heart&#x2019;s electrical activity, cochlear implants provide a sense of hearing, hydrocephalus shunts drain excess cerebrospinal fluid and subdermal birth control implants deliver contraceptive medication. Although these devices restore the form and function of the human body as well as enable drug delivery, more than 10% of these devices fail over time (<xref ref-type="bibr" rid="B95">Zhang et al., 2021</xref>) as a result of the host&#x2019;s response to the device&#x2019;s biomaterial components that are in contact with tissue. This foreign body response occurs at the biomaterial-tissue interface where it ultimately produces a fibrous capsule that separates the host from the biomaterial.</p>
<p>The foreign body response (FBR) is typically characterized by protein adsorption, inflammation and fibrosis (<xref ref-type="bibr" rid="B2">Anderson et al., 2008</xref>; <xref ref-type="bibr" rid="B38">Kalashnikov et al., 2025</xref>). When a synthetic non-biodegradable biomaterial is implanted into the human body, proteins from blood and/or other bodily fluids first rapidly adsorb onto the biomaterial surface, with adsorption profiles varying based on the material&#x2019;s surface properties (<xref ref-type="bibr" rid="B62">Rahmati and Mozafari, 2018</xref>; <xref ref-type="bibr" rid="B8">Chen et al., 2024</xref>). Then, immune cells infiltrate into the implantation site and sustain inflammation originally initiated by surgical trauma. Macrophages, in particular, not only clear the area by phagocytosing microbes and cellular debris, but they also adhere to the protein-coated biomaterial and respond to it with phenotype polarization, which allows them to reversibly acquire a specific phenotype with a defined secretome of regulatory cytokines. For example, classically-activated pro-inflammatory M1 macrophages release IL-1&#x3b2; and IL-6, whereas alternatively-activated immunoregulatory or wound-healing M2 macrophages secrete IL-10 and TGF-&#x3b2; (<xref ref-type="bibr" rid="B67">Sheikh et al., 2015</xref>; <xref ref-type="bibr" rid="B46">Liu and Segura, 2020</xref>; <xref ref-type="bibr" rid="B36">Kalashnikov and Moraes, 2022</xref>). Depending on their activation state, macrophages can utilize these cytokines to recruit and direct the behavior of other cells such as lymphocytes to establish chronic inflammation (<xref ref-type="bibr" rid="B1">Adusei et al., 2021</xref>) and/or connective tissue cells to initiate tissue repair (<xref ref-type="bibr" rid="B82">Witherel et al., 2019</xref>). Notably, fibroblasts are ultimately responsible for fibrosis around the biomaterial by laying down extracellular matrix (ECM) proteins like collagen and remodeling the resulting matrix into a fibrous capsule especially in response to stimulation by macrophages with TGF-&#x3b2;, which turns them into contractile myofibroblasts (<xref ref-type="bibr" rid="B82">Witherel et al., 2019</xref>; <xref ref-type="bibr" rid="B53">Noskovicova et al., 2021a</xref>). Ideally, the foreign body response ends with minimal fibrous encapsulation, but sometimes it can become dysregulated and result in a thick vascular contractile fibrous capsule.</p>
<p>Silicones exist in various forms ranging from oils to rubbers, but all share the same fundamental polymeric siloxane backbone. The simplest and most widely used silicone is polydimethylsiloxane (PDMS) characterized by having pendant methyl groups. It is a synthetic thermoset elastomer, which is often transparent, quite flexible and hydrophobic. Since PDMS lacks reactive functional groups and can withstand relatively harsh physicochemical conditions, it has become a widely recognized biomaterial used in many implantable medical devices (<xref ref-type="bibr" rid="B61">Quinn and Courtney, 1988</xref>; <xref ref-type="bibr" rid="B91">Zare et al., 2021</xref>). For example, it is used as a bulk material for breast implants and hydrocephalus shunts, or as a coating for pacemaker leads and cochlear implant electrode arrays. Furthermore, it is also utilized as a subdermal drug delivery vehicle for hormonal contraceptive medication. However, PDMS can elicit a strong foreign body response with significant clinical consequences: capsular contracture due to excessive fibrous encapsulation occurs in approximately 20% of women with breast implants (<xref ref-type="bibr" rid="B70">Shin et al., 2018</xref>; <xref ref-type="bibr" rid="B22">Foroushani et al., 2022</xref>; <xref ref-type="bibr" rid="B25">Gorgy et al., 2023</xref>) and around 40% of hydrocephalus shunts obstruct within 2 years of implantation presumably due to inflammatory tissue infiltration (<xref ref-type="bibr" rid="B4">Bigio and R, 1998</xref>; <xref ref-type="bibr" rid="B27">Harris and McAllister, 2012</xref>). Not only do these medical device failures cause pain and/or progression of the underlying condition, but they almost always require revision surgery, which further contributes to implant-related patient morbidity and burdens the healthcare system with additional costs. Moreover, the use of PDMS might limit the potential benefits of implantable medical devices made out of it. For instance, fibrous encapsulation of PDMS-based cochlear implants and subdermal contraceptive implants can affect the performance and/or lifetime of these devices by respectively increasing cochlear electrode impedances (<xref ref-type="bibr" rid="B21">Foggia et al., 2019</xref>) and hindering drug delivery (<xref ref-type="bibr" rid="B16">Fayzullin et al., 2021</xref>). Hence, there is a clear need to find biomaterial alternatives to PDMS that elicit a milder foreign body response with minimal fibrous encapsulation.</p>
<p>Poly (styrene-<italic>block</italic>-isobutylene-<italic>block</italic>-styrene) (SIBS), on the other hand, is a synthetic thermoplastic elastomer consisting of a self-assembled physically-crosslinked network of linear triblock copolymer styrene-isobutylene-styrene chains (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>). Given that it does not feature cleavable side groups, SIBS is thought to be resistant to oxidation, hydrolysis and enzymatic degradation making it exceptionally biodurable (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>). This has led it to be successfully used clinically as a paclitaxel-eluting coating for coronary artery stents (TAXUS<sup>&#xae;</sup> stent) (<xref ref-type="bibr" rid="B39">Kamath et al., 2006</xref>) and experimentally in ocular shunt devices (<xref ref-type="bibr" rid="B58">Pinchuk et al., 2017</xref>). In the former application, coronary artery restenosis rates are reduced from 27% to 8% compared to bare metal stents at 9 months (<xref ref-type="bibr" rid="B72">Stone et al., 2004</xref>), while &#x2013; in the latter &#x2013; no clinically significant inflammation or fibrous encapsulation is observed around ocular SIBS shunt devices (<xref ref-type="bibr" rid="B57">Pinchuk et al., 2016</xref>). However, the eye is considered an immune-privileged anatomic site where immune-mediated inflammation is naturally suppressed (<xref ref-type="bibr" rid="B73">Streilein, 2003</xref>; <xref ref-type="bibr" rid="B52">Niederkorn, 2006</xref>) and the cardiovascular system &#x2013; more specifically, the heart valves (<xref ref-type="bibr" rid="B29">Hill et al., 2021</xref>) and the arterial tunica media (<xref ref-type="bibr" rid="B76">Tellides and Pober, 2015</xref>) &#x2013; also appears to exhibit some immune privilege. This indicates that the foreign body response is likely different in these locations compared to other sites, yet there are no rigorous studies on the foreign body response to SIBS in more conventional inflammation-prone anatomic sites such as skin. In this work, we aim to evaluate the foreign body response associated with SIBS and determine if SIBS can be a suitable biomaterial alternative to PDMS. To do so, we first characterize the physicochemical properties of SIBS, then we examine how it affects macrophage-fibroblast phenotypes <italic>in vitro</italic> and finally we implant SIBS subcutaneously in mice, all while comparing it to PDMS.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<p>Unless otherwise stated, all cell culture materials and supplies were purchased from Fischer Scientific (Ottawa, ON), and all chemicals were acquired from Sigma-Aldrich (Oakville, ON). PDMS was prepared in-house using a Sylgard 184 silicone elastomer kit (No. 4019862; Dow), while medical-grade 1&#xa0;mm thick SIBS sheets (InnFocus, Inc.) were supplied directly by LP. Human monocytes (THP-1; TIB-202; ATCC) were generously donated by Dr. Lisbet Haglund (McGill University). Human primary dermal fibroblast extraction, expansion and usage was approved by the MUHC Research Ethics Board (MP-37-2020-5995). 8-week old C57BL/6J mice were obtained from the internal colony of the Animal Resources Division (ARD) at the Research Institute of the MUHC (RI-MUHC) and all mice experiments were approved by the Animal Care Committee of the RI-MUHC (MUHC-10152) in accordance with the Canadian Council on Animal Care (CCAC) guidelines.</p>
<sec id="s2-1">
<title>Biomaterial preparation</title>
<p>PDMS was prepared by mixing the polymer base with the curing agent in a 10:1 mass ratio, degassing the resulting mixture, pouring it into a Petri dish and curing it in a convection oven at 70&#xa0;&#xb0;C for 24&#xa0;h. The prolonged curing time was selected to help stiffen the PDMS and render it more hydrophilic to better match SIBS without making it excessively brittle (<xref ref-type="bibr" rid="B66">Seghir and Arscott, 2015</xref>). For tensile tests, a 3D-printed polylactic acid (PLA) ASTM D638 IV dumbbell mold was utilized; otherwise, PDMS was biopsy punched into 10&#xa0;mm disks for <italic>in vitro</italic> use or into 4&#xa0;mm disks for animal experiments. SIBS sheets were directly carefully cut into the same shapes using a scalpel or biopsy punches. To ensure sterility in experiments with cells and mice, both biomaterials were soaked in 70% ethanol for 5&#xa0;min and washed with PBS three times, and then exposed to UV for 1&#xa0;h. For cell culture, the 10&#xa0;mm biomaterial disks were also glued to the bottom of 12-well plates beforehand by using drops of uncrosslinked PDMS and placing the resulting constructs into the oven for 30&#xa0;min.</p>
</sec>
<sec id="s2-2">
<title>Tensile testing</title>
<p>To characterize the mechanical behavior of both biomaterials, tensile testing was conducted using a CellScale UniVert machine equipped with a 200&#xa0;N load cell. Briefly, the thickness, width and length of the gauge sections of the dumbbell biomaterial samples were measured with a micrometer. Then, each sample was aligned along the loading axis, securely mounted in the machine and stretched at a constant rate of 10&#xa0;mm/min until breakage. The recorded force-displacement data and the calculated original cross-sectional area of the samples was used to generate engineering stress-strain curves. The Young&#x2019;s moduli were obtained from the linear region of the stress-strain curves, which corresponded roughly to the initial 0.1% strain range, using linear regression.</p>
</sec>
<sec id="s2-3">
<title>Contact profilometry</title>
<p>A Bruker Dektak profilometer armed with a 2&#xa0;&#x3bc;m diamond-tipped stylus was utilized to study surface topography. The stylus was traversed across the biomaterial surface over a scan length of 2&#xa0;mm for a duration of 30&#xa0;s with a 3&#xa0;mg force. Surface profile data was recorded, filtered using Gaussian regression with a 0.25&#xa0;mm long cutoff and analyzed to quantify relevant surface roughness parameters (e.g., R<sub>a</sub> for average roughness, R<sub>q</sub> for root mean square roughness, R<sub>sk</sub> for surface profile skewness and R<sub>ku</sub> for surface profile kurtosis) in Vision64. Three measurements were taken from different regions of each sample to account for surface heterogeneity.</p>
</sec>
<sec id="s2-4">
<title>Contact angle goniometry</title>
<p>To assess surface wettability, static water contact angle measurements were performed using the sessile drop method with a DataPhysics OCA 15EC contact angle goniometer. 2&#xa0;&#x3bc;L of deionized water was gently deposited at a rate of 0.5&#xa0;&#x3bc;L/s on the biomaterial surface using a micro-syringe and images of the resulting droplets were captured immediately. Using the SCA20 software, droplet profile extraction was performed and contact angle values were computed with the Young-Laplace fitting algorithm. For each sample, three measurements were taken in different locations. In addition, all measurements were obtained in one session without interruption to ensure consistent ambient temperature and humidity conditions.</p>
</sec>
<sec id="s2-5">
<title>Cell culture</title>
<p>THP-1 human monocyte cultures were kept in Roswell Park Memorial Institute 1,640 medium (RPMI 1640; Gibco) supplemented with 10% fetal bovine serum (FBS), 1% antibiotic-antimycotic (AA), 1% 0.2&#xa0;mM (w/v) L-glutamine in PBS and 0.05&#xa0;mM &#x3b2;-mercaptoethanol at 37&#xa0;&#xb0;C and 5% CO<sub>2</sub> in suspension T-25 flasks. Cell counts and trypan blue live-dead assays were regularly performed to ensure an adequate cell concentration of 0.2&#x2013;0.8 million cells per mL with a viability of at least 90%. Cultures were maintained either by adding fresh complete RPMI 1640 media, starting a new flask or resuspending the entire culture in media after centrifuging it at 200&#xa0;g for 5&#xa0;min. For experiments, THP-1 monocytes between passage 3 and 8 were recovered by centrifugation, resuspended in complete RPMI 1640 media with 25&#xa0;nM phorbol 12-myristate-13 acetate (PMA) at a density of 0.15 million cells per mL, added to the biomaterials and left to differentiate into macrophages over 48&#xa0;h (<xref ref-type="fig" rid="F2">Figure 2A</xref>) as previously done elsewhere (<xref ref-type="bibr" rid="B37">Kalashnikov and Moraes, 2023</xref>). The biomaterial surfaces were then washed with pre-warmed PBS to remove unattached poorly-differentiated THP-1 cells and, after adding fresh media, the cultures were left to rest for 1&#xa0;day (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Then, 72&#xa0;h later, macrophage cultures were imaged and cellular RNA was extracted at which point conditioned media was also collected (<xref ref-type="fig" rid="F2">Figure 2A</xref>).</p>
<p>Human primary dermal fibroblasts were grown in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM; Gibco) supplemented with 10% FBS and 1% AA at 37&#xa0;&#xb0;C and 5% CO<sub>2</sub> in T-25 flasks. Cultures were trypsinized and passaged into new flasks when they reached 75% confluency. For experiments, fibroblasts from passages 5 to 8 were harvested with trypsin and either seeded at a density of 0.0125 million cells per mL into well plates or used for collagen gel contraction assays at a concentration of 1 million cells per mL (<xref ref-type="fig" rid="F3">Figure 3A</xref>). In both cases, they were subjected to a 1:1 mixture of macrophage-conditioned media and fresh complete DMEM media (<xref ref-type="fig" rid="F3">Figure 3A</xref>) where the conditioned media was first spun at 1,000&#xa0;rpm for 15&#xa0;min to remove any cellular debris as done previously (<xref ref-type="bibr" rid="B7">Chen et al., 2023</xref>).</p>
</sec>
<sec id="s2-6">
<title>Microscopy and image analysis</title>
<p>An EVOS M5000 microscope with 10x and 20x magnifications was used to capture images of cell cultures as well as stained fibrous capsule tissue sections, which were then both analyzed using ImageJ (NIH). For the former, all cells were counted in at least three fields of view for each well and freehand outlined as well as had their area and Feret diameters measured. Aspect ratio was calculated by dividing the maximum by the minimum Feret diameter. For the latter, the fibrous capsule thickness was measured in at least three locations in each capsule where it was intact with no visible gaps due to possible sectioning artifacts. Cell density was calculated by counting the number of cells within at least three 1,000&#xa0;&#x3bc;m<sup>2</sup> regions in at least three fibrous capsule samples.</p>
</sec>
<sec id="s2-7">
<title>Gene expression analysis</title>
<p>In order to study macrophage and fibroblast phenotypes, total RNA was first extracted from cell cultures using the RNeasy Fibrous Tissue Mini Kit (Qiagen) according to the manufacturer&#x2019;s instructions. RNA concentration and purity were evaluated using the NanoDrop 2000 UV-Vis spectrophotometer (Thermo Fisher Scientific). Then, cDNA was synthesized using the GoScript Reverse Transcription oligo (dT) Mix (Promega) from 500 to 1,000&#xa0;ng of total RNA following the manufacturer&#x2019;s recipe and recommended thermal cycler parameters. Finally, gene expression was assessed using quantitative polymerase chain reaction (qPCR) performed on an Applied Biosystems StepOnePlus machine with SYBR Green chemistry according to the recommended instructions. Primer sequences used for qPCR can be found in <xref ref-type="table" rid="T1">Table 1</xref>. Relative gene expression levels were obtained from three technical replicates, and calculated using the &#x394;&#x394;C<sub>T</sub> method (<xref ref-type="bibr" rid="B47">Livak and Schmittgen, 2001</xref>; <xref ref-type="bibr" rid="B74">Taylor et al., 2019</xref>) where the housekeeping GAPDH gene and the TCPS condition were used for normalization.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>RNA primer sequences used for qPCR.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene</th>
<th align="left">Forward primer sequence</th>
<th align="left">Reverse primer sequence</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<italic>GAPDH</italic>
</td>
<td align="left">5&#x2032;-TCC&#x200b;CTG&#x200b;AGC&#x200b;TGA&#x200b;ACG&#x200b;GGA&#x200b;AG-3&#x2032;</td>
<td align="left">5&#x2032;-GGA&#x200b;GGA&#x200b;GTG&#x200b;GGT&#x200b;GTC&#x200b;GCT&#x200b;GT-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>NOS2</italic>
</td>
<td align="left">5&#x2032;-GTT&#x200b;CTC&#x200b;AAG&#x200b;GCA&#x200b;CAG&#x200b;GTC&#x200b;TC-3&#x2032;</td>
<td align="left">5&#x2032;-GCA&#x200b;GGT&#x200b;CAC&#x200b;TTA&#x200b;TGT&#x200b;CAC&#x200b;TTA&#x200b;TC-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>IRF5</italic>
</td>
<td align="left">5&#x2032;-ACC&#x200b;TCA&#x200b;GCC&#x200b;CTA&#x200b;CAA&#x200b;GAT&#x200b;CTA&#x200b;CGA-3&#x2032;</td>
<td align="left">5&#x2032;-AAC&#x200b;ATC&#x200b;CTC&#x200b;TGC&#x200b;AGC&#x200b;TCT&#x200b;TCC&#x200b;TC-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>ARG1</italic>
</td>
<td align="left">5&#x2032;-GAC&#x200b;AGA&#x200b;CTA&#x200b;GGA&#x200b;ATT&#x200b;GGC&#x200b;AAG&#x200b;GTG-3&#x2032;</td>
<td align="left">5&#x2032;-GGG&#x200b;TCC&#x200b;AGT&#x200b;CCG&#x200b;TCA&#x200b;ACA&#x200b;TCA&#x200b;AAA-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>STAT6</italic>
</td>
<td align="left">5&#x2032;-ATC&#x200b;ACC&#x200b;ATT&#x200b;GCC&#x200b;CAT&#x200b;GTC&#x200b;ATC&#x200b;C-3&#x2032;</td>
<td align="left">5&#x2032;-ACC&#x200b;CAT&#x200b;CTG&#x200b;TTC&#x200b;AGG&#x200b;CTT&#x200b;GTA&#x200b;GT-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>IL1B</italic>
</td>
<td align="left">5&#x2032;-GAC&#x200b;AAG&#x200b;CTG&#x200b;AGG&#x200b;AAG&#x200b;ATG&#x200b;CT-3&#x2032;</td>
<td align="left">5&#x2032;-AGC&#x200b;GTG&#x200b;CAG&#x200b;TTC&#x200b;AGT&#x200b;GAT&#x200b;CG-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>IL6</italic>
</td>
<td align="left">5&#x2032;-TGA&#x200b;ACC&#x200b;TTC&#x200b;CAA&#x200b;AGA&#x200b;TGG&#x200b;CTG-3&#x2032;</td>
<td align="left">5&#x2032;-CAA&#x200b;ACT&#x200b;CCA&#x200b;AAA&#x200b;GAC&#x200b;CAG&#x200b;TGA&#x200b;TG-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>CXCL8</italic>
</td>
<td align="left">5&#x2032;-CCT&#x200b;TCC&#x200b;TGA&#x200b;TTT&#x200b;CTG&#x200b;CAG&#x200b;CT-3&#x2032;</td>
<td align="left">5&#x2032;-TGG&#x200b;GGT&#x200b;GGA&#x200b;AAG&#x200b;GTT&#x200b;TGG&#x200b;AG-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>TNF</italic>
</td>
<td align="left">5&#x2032;-TGA&#x200b;CAA&#x200b;GCC&#x200b;TGT&#x200b;AGC&#x200b;CCA&#x200b;TG-3&#x2032;</td>
<td align="left">5&#x2032;-TTG&#x200b;AAG&#x200b;AGG&#x200b;ACC&#x200b;TGG&#x200b;GAG&#x200b;TA-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>TFGB1</italic>
</td>
<td align="left">5&#x2032;-GCA&#x200b;CGT&#x200b;GGA&#x200b;GCT&#x200b;GTA&#x200b;CCA&#x200b;GA-3&#x2032;</td>
<td align="left">5&#x2032;-CGC&#x200b;ACA&#x200b;ACT&#x200b;CCG&#x200b;GTG&#x200b;GAC&#x200b;ATC-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>IL10</italic>
</td>
<td align="left">5&#x2032;-GGG&#x200b;GAA&#x200b;GGT&#x200b;GAA&#x200b;GGC&#x200b;TCA&#x200b;ATC&#x200b;AAA-3&#x2032;</td>
<td align="left">5&#x2032;-TCT&#x200b;CGA&#x200b;AGC&#x200b;ATG&#x200b;TTA&#x200b;GGC&#x200b;AGG&#x200b;TT-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>COL1A1</italic>
</td>
<td align="left">5&#x2032;-GCT&#x200b;TCA&#x200b;CCT&#x200b;ACA&#x200b;GCG&#x200b;TCA&#x200b;CT-3&#x2032;</td>
<td align="left">5&#x2032;-GAG&#x200b;GGA&#x200b;GTT&#x200b;TAC&#x200b;AGG&#x200b;AAG&#x200b;CA-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>COL3A1</italic>
</td>
<td align="left">5&#x2032;-TGC&#x200b;CCC&#x200b;AAC&#x200b;CCA&#x200b;GAA&#x200b;ATT&#x200b;CC-3&#x2032;</td>
<td align="left">5&#x2032;-GGA&#x200b;ATA&#x200b;CCA&#x200b;GGG&#x200b;TCA&#x200b;CCA&#x200b;TT-3&#x2032;</td>
</tr>
<tr>
<td align="left">
<italic>ACTA2</italic>
</td>
<td align="left">5&#x2032;-CCG&#x200b;GGA&#x200b;GAA&#x200b;AAT&#x200b;GAC&#x200b;TCA&#x200b;AA-3&#x2032;</td>
<td align="left">5&#x2032;-TAG&#x200b;ATG&#x200b;GGG&#x200b;ACA&#x200b;TTG&#x200b;TGG&#x200b;GT-3&#x2032;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-8">
<title>Collagen gel contraction assay</title>
<p>To assess fibroblast contractility, human primary dermal fibroblasts were embedded in collagen gels as previously done elsewhere (<xref ref-type="bibr" rid="B14">Dubois et al., 2019</xref>; <xref ref-type="bibr" rid="B35">Kalashnikov and Moraes, 2019</xref>). Briefly, a neutralized collagen-cell mixture was prepared according to the recipe presented in <xref ref-type="table" rid="T2">Table 2</xref> on ice and left to polymerize in 48-well plates inside of an incubator for roughly an hour. Then, a syringe needle was used to release the resulting collagen gels from the well edges in order to initiate free contraction, and a 1:1 mixture of macrophage-conditioned media and fresh complete DMEM media was added to the wells. Finally, the contracted gels were imaged 72&#xa0;h later and contraction extent was quantified as a percentage by dividing the change in gel area at 3&#xa0;days by the original area. To evaluate whether cell number affected gel contraction, the contracted gels were also digested with collagenase and total DNA was extracted using the DNeasy Blood &#x26; Tissue Kit (Qiagen) according to the manufacturer&#x2019;s instructions. DNA content was then quantified with the NanoDrop 2000 UV-Vis spectrophotometer (Thermo Fisher Scientific).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Collagen gel recipe.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Component</th>
<th align="left">Volume (&#x3bc;L)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">10X DMEM</td>
<td align="left">20</td>
</tr>
<tr>
<td align="left">1M sodium hydroxide (NaOH)</td>
<td align="left">4.5</td>
</tr>
<tr>
<td align="left">Sterile water</td>
<td align="left">15.5</td>
</tr>
<tr>
<td align="left">7.5% sodium bicarbonate (NaHCO<sub>3</sub>) buffer</td>
<td align="left">10</td>
</tr>
<tr>
<td align="left">1X DMEM</td>
<td align="left">50</td>
</tr>
<tr>
<td align="left">3&#xa0;mg/mL bovine collagen type I (VWR)</td>
<td align="left">150</td>
</tr>
<tr>
<td align="left">Cell suspension</td>
<td align="left">50</td>
</tr>
<tr>
<td align="left">Final 1.5&#xa0;mg/mL collagen gel volume</td>
<td align="left">300</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-9">
<title>Biomaterial implantation surgery</title>
<p>PDMS and SIBS disks were implanted under the dorsal skin in mice in order to evaluate the foreign body response to both biomaterials. First, the mice were given slow release buprenorphine (1&#xa0;mg/kg) and carprofen (20&#xa0;mg/kg) analgesia, and then anesthetized using isoflurane inhalation (3% in 1.5&#xa0;L/min oxygen) in an induction chamber. While maintaining isoflurane anesthesia (2% in 1&#xa0;L/min oxygen) using a nosecone system, the dorsum was shaved with an electric shaver, and disinfected with three alternating scrubs of 2% chlorhexidine and 70% ethanol. Then, a roughly 1&#xa0;cm incision was made on the bulge at the midline in the dorsal skin to ensure reproducible surgical site healing (<xref ref-type="bibr" rid="B83">Yampolsky et al., 2024</xref>) (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Using blunt dissection, two lateral subcutaneous pockets were created on each side of the incision and irrigated with saline. After delivering a few drops of lidocaine-bupivacaine solution for local analgesia, two PDMS and two SIBS disks were inserted into the resulting pockets away from the midline (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Finally, the incision was closed using simple interrupted stitches with 4-0 polypropylene sutures. Surgery was performed on a heating pad, ophthalmic ointment was applied as needed and isotonic fluids (25&#xa0;mL/kg) were administered. All mice were monitored post-operatively until full recovery, returned to their cages and received carprofen analgesia daily for 3 days. Mice were housed in an animal facility inside ventilated cages in groups of three to five under standard conditions with a 12-h light/dark cycle, controlled temperature and humidity, and <italic>ad libitum</italic> access to food and water.</p>
</sec>
<sec id="s2-10">
<title>Fibrous capsule tissue histology</title>
<p>At either postoperative day 7 or 28, mice were euthanized with carbon dioxide asphyxiation under isoflurane anesthesia followed by confirmation via thoracotomy. Following euthanasia, the incision was reopened and the skin was reflected along with the encapsulated biomaterial disks. Then, the implants with surrounding fibrous capsule tissue were carefully excised along with adjacent skin and immediately fixed in 10% neutral-buffered formalin for at least 48&#xa0;h at 4&#xa0;&#xb0;C until processing and embedding in paraffin. Embedded tissues were sectioned using a Leica microtome at 5&#xa0;&#x3bc;m thickness, and stained with hematoxylin and eosin (H&#x26;E) as well as Masson&#x2019;s trichrome (MT).</p>
</sec>
<sec id="s2-11">
<title>Statistical analysis</title>
<p>All biomaterial characterization tests were performed on more than three material samples and all biological experiments included at least three biological replicates. Data were analyzed in Microsoft Excel using two-sided unpaired or paired t-tests and one-way analysis of variance (ANOVA) as applicable with statistical significance set at p-value &#x3c;0.05.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and discussion</title>
<sec id="s3-1">
<title>SIBS and PDMS have comparable physicochemical properties</title>
<p>Since both biomaterials look virtually the same by eye (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>), we first compared their physicochemical properties. We conducted tensile testing (<xref ref-type="fig" rid="F1">Figures 1C,D</xref>), contact profilometry (<xref ref-type="fig" rid="F1">Figures 1E&#x2013;G</xref>) and contact angle goniometry (<xref ref-type="fig" rid="F1">Figures 1H&#x2013;J</xref>) to characterize the stiffness, topography and wettability of both biomaterials.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Physicochemical characterization of PDMS and SIBS. <bold>(A,B)</bold> Photographs of <bold>(A)</bold> PDMS and <bold>(B)</bold> SIBS disks. <bold>(C)</bold> Representative stress-strain curves for PDMS and SIBS, and <bold>(D)</bold> corresponding Young&#x2019;s moduli that are within the same order of magnitude. <bold>(E)</bold> Example surface profiles, and <bold>(F,G)</bold> associated surface topography parameters for PDMS and SIBS with roughness values in the same 10-100&#xa0;nm range. <bold>(H,I)</bold> Representative photographs of water droplets on <bold>(H)</bold> PDMS and <bold>(I)</bold> SIBS, and <bold>(J)</bold> matching contact angle values that are above 90&#xb0;. Despite some differences, PDMS and SIBS are visually similar and have comparable physicochemical properties. Data reported as mean &#x2b;/- standard deviation.</p>
</caption>
<graphic xlink:href="fbioe-14-1748501-g001.tif">
<alt-text content-type="machine-generated">Panel A and B show top views of PDMS and SIBS biomaterial disks with diameter scale bars. Panel C is a stress-strain graph comparing PDMS and SIBS, showing higher stress in PDMS. Panel D presents a bar chart of Young&#x2019;s modulus, where SIBS is significantly higher. Panel E is a surface profile plot showing greater vertical deviation for SIBS. Panel F compares surface roughness, indicating higher average and root mean square roughness for SIBS. Panel G displays bar graphs of surface skewness and kurtosis, with higher skewness in SIBS. Panels H and I are water droplet images on PDMS and SIBS surfaces, respectively. Panel J is a bar chart showing a larger water contact angle for PDMS compared to SIBS, indicating significant difference.</alt-text>
</graphic>
</fig>
<p>We observed in the tensile testing experiments that SIBS behaves differently under load compared to PDMS. While PDMS is characterized by a nonlinearly elastic stress-strain relationship with strain-stiffening, SIBS displays strain-softening behavior (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Indeed, although SIBS is initially stiffer than PDMS, it becomes softer when its strain extends beyond 0.25 at which point the slopes of the stress-strain curves of both materials are roughly the same. This difference may be attributed to crosslinking, as SIBS is physically crosslinked with Van der Waals forces where interactions weaken with increasing strains as opposed to the much stronger covalent bonds that hold the chemically crosslinked PDMS together. The Young&#x2019;s moduli are also significantly different with 2.98 &#xb1; 0.37&#xa0;MPa for PDMS and 4.97 &#xb1; 0.60&#xa0;MPa for SIBS (p-value &#x3d; 0.004; <xref ref-type="fig" rid="F1">Figure 1D</xref>), which is consistent with literature on PDMS with extended curing time (<xref ref-type="bibr" rid="B66">Seghir and Arscott, 2015</xref>) and SIBS (<xref ref-type="bibr" rid="B55">Ovcharenko et al., 2019</xref>). Nevertheless, the stiffness of these biomaterials is within the same order of magnitude.</p>
<p>Upon careful inspection, it appears that SIBS does not reflect light as well as PDMS (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>), suggesting different surface topography between the materials. In fact, contact profilometry shows that the surface profile of PDMS is much flatter than that of SIBS, which has prominent peaks and valleys (<xref ref-type="fig" rid="F1">Figure 1E</xref>). The surface roughness parameters echo this observation: both average and root mean square roughness values are 72.3 &#xb1; 1.5&#xa0;nm and 89.0 &#xb1; 2.4&#xa0;nm for SIBS as expected (<xref ref-type="bibr" rid="B86">Yuan et al., 2014a</xref>) compared to 11.3 &#xb1; 4.3&#xa0;nm and 13.5 &#xb1; 4.7&#xa0;nm for PDMS (p-values &#x3c;10<sup>&#x2212;5</sup>; <xref ref-type="fig" rid="F1">Figure 1F</xref>). The skewness of the PDMS surface profile is also significantly higher than that of SIBS indicating that the PDMS surface has more valleys (p-value &#x3d; 0.017), while its kurtosis is not significantly different at an approximate value of 3 suggesting that the surface features of both biomaterials are neither too flat nor sharp (<xref ref-type="fig" rid="F1">Figure 1G</xref>). Despite these differences, the scale of the topographical features of both biomaterials is in the same 10-100&#xa0;nm range.</p>
<p>In terms of wettability, water droplets tend to be more spherical on PDMS (<xref ref-type="fig" rid="F1">Figures 1H,I</xref>), indicating that PDMS is more hydrophobic than SIBS. Using contact angle goniometry, the contact angle is measured at 115.1 &#xb1; 3.8&#xb0; for PDMS and 100.3 &#xb1; 5.4&#xb0; for SIBS (p-value &#x3c;10<sup>&#x2212;5</sup>; <xref ref-type="fig" rid="F1">Figure 1J</xref>) in accordance with SIBS literature (<xref ref-type="bibr" rid="B55">Ovcharenko et al., 2019</xref>; <xref ref-type="bibr" rid="B86">Yuan et al., 2014a</xref>; <xref ref-type="bibr" rid="B89">Yuan et al., 2016a</xref>). Although the contact angles are significantly different, both biomaterials are still considered hydrophobic, as their contact angles are above 90&#xb0;.</p>
</sec>
<sec id="s3-2">
<title>Macrophages express more pro-inflammatory genes on SIBS</title>
<p>After demonstrating that PDMS and SIBS are comparable as materials, we then questioned if they would affect macrophages differently. We seeded THP-1 monocytes on both biomaterials, differentiated them into macrophages with 25&#xa0;nM PMA for 48&#xa0;h and let them rest for another 24&#xa0;h to minimize inflammatory gene upregulation as recommended (<xref ref-type="bibr" rid="B48">Lund et al., 2016</xref>) (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Macrophage morphology was studied using microscopy (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;G</xref>), and expression of key macrophage polarization markers (<italic>NOS2</italic>, <italic>IRF5</italic>, <italic>ARG1</italic> and <italic>STAT6</italic>) as well as inflammatory (<italic>IL1B</italic>, <italic>IL6</italic>, <italic>CXCL8</italic> and <italic>TNF</italic>) and anti-inflammatory (<italic>TGFB1</italic> and <italic>IL10</italic>) genes was evaluated using reverse transcription quantitative polymerase chain reaction (RT-qPCR) (<xref ref-type="fig" rid="F2">Figures 2H&#x2013;J</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Macrophage phenotype on SIBS compared to PDMS. <bold>(A)</bold> Experimental diagram, demonstrating THP-1 monocyte differentiation into macrophages with 25&#xa0;nM phorbol 12-myristate-13 acetate (PMA). <bold>(B&#x2013;D)</bold> Representative microscope images of macrophages cultured on <bold>(B)</bold> tissue culture polystyrene (TCPS), <bold>(C)</bold> PDMS and <bold>(D)</bold> SIBS. <bold>(E)</bold> Macrophage attachment, <bold>(F)</bold> spread area and <bold>(G)</bold> elongation on the three different substrates, demonstrating that macrophages are smaller and more elongated on SIBS. <bold>(H&#x2013;J)</bold> Macrophage expression of <bold>(H)</bold> M1 and M2 polarization markers as well as <bold>(I)</bold> pro-inflammatory and <bold>(J)</bold> anti-inflammatory genes across all three materials, indicating that macrophages adopt a slightly more pro-inflammatory phenotype on SIBS compared to PDMS. Data reported as mean &#x2b;/- standard deviation except for <bold>(F)</bold> and <bold>(G)</bold> where standard error is used with n &#x3d; 75&#x2013;100 per material.</p>
</caption>
<graphic xlink:href="fbioe-14-1748501-g002.tif">
<alt-text content-type="machine-generated">Figure displaying a THP-1 monocyte differentiation workflow (panel A) followed by three microscopy images showing cell morphology on TCPS, PDMS, and SIBS (panels B, C, D). Quantitative bar graphs compare cell count (E), cell area (F), and aspect ratio (G) across substrates. Additional bar charts display gene expression data for NOS2, IRF5, ARG1, STAT6 (H) and IL1B, IL6, CXCL8, TNF (I) and TGFB1, IL10 (J), highlighting significant differences with asterisks between substrates. Scale bars indicate one hundred micrometers in images.</alt-text>
</graphic>
</fig>
<p>Even though it was clear that macrophages look different on tissue culture polystyrene (TCPS) (<xref ref-type="fig" rid="F2">Figure 2B</xref>) compared to PDMS (<xref ref-type="fig" rid="F2">Figure 2C</xref>) and SIBS (<xref ref-type="fig" rid="F2">Figure 2D</xref>), the number of cells per field of view across all three substrates was not significantly different (<xref ref-type="fig" rid="F2">Figure 2E</xref>), indicating that macrophages attach equally well to both biomaterials and to a similar extent as to TCPS. This suggests that observed morphological changes are not due to cell attachment differences but are rather representations of differences in macrophage phenotype. Interestingly, macrophages are smaller and more elongated on SIBS compared to PDMS, as evidenced by a significantly lower cell spread area (p-value &#x3d; 0.001; <xref ref-type="fig" rid="F2">Figure 2F</xref>) and a higher cell aspect ratio (p-value &#x3d; 0.003; <xref ref-type="fig" rid="F2">Figure 2G</xref>). Although the link between THP-1 macrophage morphology and phenotype has not been fully established yet, literature suggests that cell spread area is associated with activation and elongated morphology corresponds to pro-inflammatory M1 macrophage polarization (<xref ref-type="bibr" rid="B37">Kalashnikov and Moraes, 2023</xref>; <xref ref-type="bibr" rid="B92">Zh et al., 2015</xref>). Given these correlations, SIBS might be perhaps polarizing macrophages more towards an M1 phenotype but generally activating less macrophages compared to PDMS although this remains speculative.</p>
<p>In terms of gene expression, only the expression of <italic>NOS2</italic> out of the two M1 polarization markers (<italic>NOS2</italic> and <italic>IRF5</italic>) is significantly different between both biomaterials with macrophages on SIBS transcribing less of it (p-value &#x3d; 0.042; <xref ref-type="fig" rid="F2">Figure 2H</xref>). Since there are no significant differences for M2 polarization markers (<italic>ARG1</italic> and <italic>STAT6</italic>), this suggests that macrophages on SIBS are less polarized towards an M1 phenotype. Seemingly in contradiction, these macrophages also have a significantly higher expression of pro-inflammatory <italic>CXCL8</italic> and <italic>TNF</italic> genes (p-values &#x3d; 0.013 and 0.042; <xref ref-type="fig" rid="F2">Figure 2I</xref>), and a significantly lower expression of the pro-fibrotic <italic>TGFB1</italic> gene (p-value &#x3d; 0.037; <xref ref-type="fig" rid="F2">Figure 2J</xref>). That being said, a single marker cannot accurately define macrophage polarization and, as such, we believe that macrophages cultured on SIBS might be polarized towards a slightly more pro-inflammatory phenotype compared to those on PDMS given their more elongated morphology and their higher expression of pro-inflammatory genes. However, more functional macrophage assays such as measurements of secreted cytokines are needed to further clarify the phenotype of THP-1 macrophages cultured on SIBS. Furthermore, although THP-1 macrophages were used due to ease of culture and availability while being human in origin, they may not accurately capture phenotype polarization shifts compared to primary macrophage cells (<xref ref-type="bibr" rid="B6">Chanput et al., 2014</xref>; <xref ref-type="bibr" rid="B75">Tedesco et al., 2018</xref>), which could potentially resolve the apparent contradictions in gene expression and should be used in future studies aiming to confirm the preliminary observations made here.</p>
</sec>
<sec id="s3-3">
<title>Fibroblasts express pro-inflammatory genes and are less contractile when exposed to conditioned media from macrophages cultured on SIBS</title>
<p>Given the altered phenotype of macrophages cultured on SIBS, we next assessed whether these macrophages could, in turn, influence fibroblast behavior. To study this, we added media conditioned by macrophages grown on both biomaterials to fibroblasts cultured on standard tissue culture plastic as per previous work (<xref ref-type="bibr" rid="B7">Chen et al., 2023</xref>) and to fibroblast-laden collagen gels (<xref ref-type="fig" rid="F3">Figure 3A</xref>) in order to respectively evaluate their gene expression and contractility.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Fibroblast phenotype when exposed to conditioned media from macrophages cultured on TCPS, PDMS and SIBS. <bold>(A)</bold> Experimental diagram, illustrating how macrophage conditioned media was used to interrogate fibroblast phenotype. <bold>(B&#x2013;E)</bold> Fibroblast expression of <bold>(B,C)</bold> ECM-related genes and <bold>(D,E)</bold> pro-inflammatory genes at <bold>(B,D)</bold> 24&#xa0;h and at <bold>(C,E)</bold> 72&#xa0;h, highlighting upregulation of pro-inflammatory genes in the SIBS condition. <bold>(F&#x2013;I)</bold> Representative photographs of contracted fibroblast-laden collagen gels at 72&#xa0;h after being subjected to <bold>(F)</bold> unaltered fresh media or conditioned media from macrophages cultured on <bold>(G)</bold> TCPS, <bold>(H)</bold> PDMS and <bold>(I)</bold> SIBS. <bold>(J)</bold> Contraction extent for the various gels at 72&#xa0;h, demonstrating reduced fibroblast contractility in the SIBS condition. <bold>(K)</bold> Amount of DNA extracted from contracted fibroblast-laden collagen gels, indicating indirectly that all gels have the same amount of cells and proliferation is not a confounding factor for the observed contractility changes. Data reported as mean &#x2b;/- standard deviation.</p>
</caption>
<graphic xlink:href="fbioe-14-1748501-g003.tif">
<alt-text content-type="machine-generated">Diagram at the top outlines an experimental workflow involving human primary dermal fibroblasts, conditioned media, collagen gel contraction, and microscopy. Bar graphs labeled B to E display gene expression levels for various genes and conditions at 24 and 72 hours, comparing None, TCPS, PDMS, and SIBS groups. Images F to I show collagen gels after contraction for each condition, with distinct contraction patterns. Graph J quantifies contraction extent, indicating a significant difference marked by an asterisk. Graph K displays DNA content per gel, showing no significant difference. Scale bars are 5 millimeters in gel images.</alt-text>
</graphic>
</fig>
<p>Since macrophages on SIBS had a higher expression of <italic>TNF</italic> as well as a lower expression of <italic>TGFB1</italic> than those on PDMS, we expected their conditioned media to downregulate collagen (<italic>COL1A1</italic> and <italic>COL3A1</italic>) and alpha smooth muscle actin (&#x3b1;-SMA encoded by <italic>ACTA2</italic>) genes, as TNF-&#x3b1; (<xref ref-type="bibr" rid="B24">Goldberg et al., 2007</xref>; <xref ref-type="bibr" rid="B98">Zhu et al., 2021</xref>) and TGF-&#x3b2; (<xref ref-type="bibr" rid="B43">Li et al., 2006</xref>; <xref ref-type="bibr" rid="B17">Finnson et al., 2013</xref>) work antagonistically to affect ECM production and myofibroblast differentiation characterized by high &#x3b1;-SMA levels. Surprisingly however, the expression of <italic>COL1A1</italic>, <italic>COL3A1</italic> and <italic>ACTA2</italic> is not significantly different at both 24&#xa0;h (<xref ref-type="fig" rid="F3">Figure 3B</xref>) and 72&#xa0;h (<xref ref-type="fig" rid="F3">Figure 3C</xref>) between the PDMS and SIBS conditions. Instead, pro-inflammatory <italic>IL6</italic> and <italic>CXCL8</italic> genes are significantly upregulated in fibroblasts exposed to SIBS-macrophage conditioned media at 24&#xa0;h (p-values &#x3d; 0.016 and 0.035; <xref ref-type="fig" rid="F3">Figure 3D</xref>) and this is maintained until 72&#xa0;h for <italic>IL6</italic> (p-value &#x3d; 0.019; <xref ref-type="fig" rid="F3">Figure 3E</xref>). Given the growing evidence that fibroblast activation is not restricted to myofibroblast differentiation and can result in adoption of a secretory or immune-interacting phenotype (<xref ref-type="bibr" rid="B10">Davidson et al., 2021</xref>; <xref ref-type="bibr" rid="B65">Schuster et al., 2021</xref>), we hypothesize that fibroblasts exposed to conditioned media from macrophages cultured on SIBS acquire an inflammatory phenotype characterized by secretion of inflammatory cytokines as opposed to a contractile or tissue-remodeling one.</p>
<p>To confirm whether the fibroblasts in the SIBS condition are shifting away from a contractile phenotype, we decided to look at their level of contractility using collagen gel contraction assays (<xref ref-type="fig" rid="F3">Figures 3F&#x2013;I</xref>). Indeed, fibroblasts exposed to conditioned media from macrophages cultured on SIBS contracted the collagen gels significantly less than those in the PDMS condition (p-value &#x3d; 0.028; <xref ref-type="fig" rid="F3">Figure 3J</xref>). To rule out proliferation as a potential confounder, we also digested the contracted collagen gels and quantified the amount of DNA in them as an indirect measure of cell number. There were no significant differences in amount of DNA extracted (<xref ref-type="fig" rid="F3">Figure 3K</xref>), indicating that the fibroblasts in the SIBS condition are indeed less contractile. This is consistent with previous findings that interleukin-8 (IL-8 encoded by <italic>CXCL8</italic>) (<xref ref-type="bibr" rid="B33">Iocono et al., 2000</xref>; <xref ref-type="bibr" rid="B23">Ghazarian et al., 2000</xref>) and TNF-&#x3b1; (<xref ref-type="bibr" rid="B24">Goldberg et al., 2007</xref>; <xref ref-type="bibr" rid="B98">Zhu et al., 2021</xref>) suppress fibroblast contractility. Further work with protein assays is however required to fully tease apart the phenotype of fibroblasts exposed to conditioned media from THP-1 macrophages grown on PDMS and SIBS, as these fibroblasts might actually be adopting a mixed phenotype with myofibroblast (e.g., retained expression of <italic>ACTA2</italic>, <italic>COL1A1</italic> and <italic>COL3A1</italic> genes) and secretory (e.g., acquired expression of <italic>IL6</italic> and <italic>CXCL8</italic> genes as well as reduced contractility) characteristics.</p>
</sec>
<sec id="s3-4">
<title>Fibrotic encapsulation around SIBS implants is diminished in mice</title>
<p>To see if these <italic>in vitro</italic> observations translate to substantial differences between PDMS and SIBS in eliciting a foreign body response <italic>in vivo</italic>, PDMS and SIBS disks were implanted subcutaneously in mice (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The resulting encapsulated implants were harvested either 7&#xa0;days or 28&#xa0;days later and the capsular tissue was analyzed histologically. At 7&#xa0;days, the fibrous capsules around both biomaterials were highly cellular with minimal collagen deposition indicative of the initial phase of the foreign body response (<xref ref-type="fig" rid="F4">Figures 4B&#x2013;E</xref>), while fibrous capsules at 28&#xa0;days were more consistent with later stages of the foreign body response, being thicker, less cellular and rich in collagen (<xref ref-type="fig" rid="F4">Figures 4F&#x2013;I</xref>). For both time points, fibrous encapsulation around SIBS implants is significantly reduced compared to PDMS (p-values &#x3d; 0.017 and 0.0002; <xref ref-type="fig" rid="F4">Figure 4J</xref>). Moreover, the cell density of the fibrous capsules is significantly lower for SIBS (p-value &#x3d; 0.0002; <xref ref-type="fig" rid="F4">Figure 4K</xref>), indicating that the capsular tissue is less active. Along with more advanced <italic>in vitro</italic> macrophage-fibroblast direct co-culture experiments with more comprehensive readouts, immunohistochemistry staining for macrophage polarization and extracellular matrix-related markers is however necessary to understand the inflammatory and fibrotic profile of these fibrous capsules as well as the mechanism resulting in our findings.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Foreign body response in mice to PDMS and SIBS. <bold>(A)</bold> Illustration of a mouse post-biomaterial implantation surgery, emphasizing the closed incision on the bulge of the dorsum and the four implant locations. <bold>(B&#x2013;I)</bold> Representative microscope images of <bold>(B,C,F,G)</bold> hematoxylin &#x26; eosin <bold>(H,E)</bold> and <bold>(D,E,H,I)</bold> Masson&#x2019;s trichrome stained fibrous capsule tissue sections harvested <bold>(B&#x2013;E)</bold> 7&#xa0;days or <bold>(F&#x2013;I)</bold> 28&#xa0;days postoperatively. <bold>(J)</bold> Fibrous capsule thickness around PDMS and SIBS implants at 7&#xa0;days and 28&#xa0;days, demonstrating reduced fibrous encapsulation around SIBS. <bold>(K)</bold> Cell density at 28&#xa0;days, indicating a reduction in the amount cells around SIBS implants. Data reported as mean &#x2b;/- standard deviation except for <bold>(K)</bold> where standard error is used with n &#x3d; 9 per material.</p>
</caption>
<graphic xlink:href="fbioe-14-1748501-g004.tif">
<alt-text content-type="machine-generated">Diagram showing a mouse with labeled implant sites for PDMS and SIBS, bar graphs comparing capsule thickness and cell density at 7 and 28 days for both materials, and histological images of tissue samples stained to evaluate capsule morphology and cell infiltration at two time points for both PDMS and SIBS implants.</alt-text>
</graphic>
</fig>
<p>Nevertheless, the findings presented here suggest that, in contrast to PDMS, SIBS elicits a milder foreign body response. Previously, unmodified SIBS has only been shown to achieve the same level of tissue reactivity as silicone under rabbit conjunctiva (<xref ref-type="bibr" rid="B51">Nakamura et al., 2022</xref>) within the immune privileged environment of the eye. Hence, our work not only extends this observation to skin but also demonstrates that SIBS exhibits superior biocompatibility in this more inflammation-prone anatomic site, which is not surprising given that immune privilege dampens the foreign body response (<xref ref-type="bibr" rid="B28">Hernandez et al., 2021</xref>). Furthermore, our work suggests that these findings are generalizable to other non-immune privileged locations in the body.</p>
<p>The mechanism behind this apparent diminished foreign body response is still unclear, especially in comparison to PDMS, and the hypotheses made here are speculative. According to the literature, stiffness is correlated with more fibrosis via increased biomaterial-tissue mechanical mismatch (<xref ref-type="bibr" rid="B5">Blakney et al., 2012</xref>; <xref ref-type="bibr" rid="B59">Previtera and Sengupta, 2015</xref>; <xref ref-type="bibr" rid="B34">Jansen et al., 2018</xref>; <xref ref-type="bibr" rid="B71">Sridharan et al., 2019</xref>; <xref ref-type="bibr" rid="B54">Noskovicova et al., 2021b</xref>; <xref ref-type="bibr" rid="B26">Goswami et al., 2021</xref>), whereas surface roughness with characteristic lengths similar to the size of cells (<xref ref-type="bibr" rid="B77">Vassey et al., 2020</xref>; <xref ref-type="bibr" rid="B13">Doloff et al., 2021</xref>) and hydrophilicity (<xref ref-type="bibr" rid="B32">Hotchkiss et al., 2016</xref>; <xref ref-type="bibr" rid="B49">Lv et al., 2018</xref>; <xref ref-type="bibr" rid="B78">Visalakshan et al., 2019</xref>) are associated with beneficial anti-inflammatory macrophage phenotypes. Hence, the observation that SIBS results in less fibrous encapsulation could perhaps be explained by its significantly higher surface roughness and lower contact angle. However, it is unlikely that the small, but significant, differences in physicochemical properties between the two biomaterials are responsible for this, as the effect of these is only really significant with larger differences in the Pa-to-kPa range for stiffness (<xref ref-type="bibr" rid="B5">Blakney et al., 2012</xref>; <xref ref-type="bibr" rid="B59">Previtera and Sengupta, 2015</xref>; <xref ref-type="bibr" rid="B34">Jansen et al., 2018</xref>; <xref ref-type="bibr" rid="B71">Sridharan et al., 2019</xref>; <xref ref-type="bibr" rid="B54">Noskovicova et al., 2021b</xref>; <xref ref-type="bibr" rid="B26">Goswami et al., 2021</xref>), at the microscale for roughness (<xref ref-type="bibr" rid="B77">Vassey et al., 2020</xref>; <xref ref-type="bibr" rid="B13">Doloff et al., 2021</xref>) and across the defined hydrophobicity-hydrophilicity limit for wettability (<xref ref-type="bibr" rid="B32">Hotchkiss et al., 2016</xref>; <xref ref-type="bibr" rid="B49">Lv et al., 2018</xref>; <xref ref-type="bibr" rid="B78">Visalakshan et al., 2019</xref>). Instead, we believe it is the phase separation that is inherent to block copolymers that drives our findings through differential protein adsorption, as SIBS displays a phase-separated surface morphology (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>; <xref ref-type="bibr" rid="B63">Ranade et al., 2005</xref>; <xref ref-type="bibr" rid="B68">Shen et al., 2021</xref>) and this greatly influences protein adsorption (<xref ref-type="bibr" rid="B3">Bhushan and Schricker, 2014</xref>; <xref ref-type="bibr" rid="B18">Firkowska-Boden et al., 2018</xref>). Perhaps, the hard polystyrene and soft polyisobutylene phases of SIBS preferentially adsorb a particular set of proteins that polarize slightly more macrophages into a pro-inflammatory phenotype with enhanced <italic>TNF</italic> and <italic>CXCL8</italic> expression as well as decreased <italic>TGFB1</italic> expression. This, in turn, could stimulate fibroblasts to shift away from a contractile phenotype to an inflammatory one (<xref ref-type="bibr" rid="B10">Davidson et al., 2021</xref>; <xref ref-type="bibr" rid="B65">Schuster et al., 2021</xref>) with increased expression of <italic>IL6</italic> and <italic>CXCL8</italic> as well as decreased contractility (<xref ref-type="bibr" rid="B24">Goldberg et al., 2007</xref>; <xref ref-type="bibr" rid="B98">Zhu et al., 2021</xref>; <xref ref-type="bibr" rid="B33">Iocono et al., 2000</xref>; <xref ref-type="bibr" rid="B23">Ghazarian et al., 2000</xref>). Given the reduced amount of fibroblasts within the SIBS fibrous capsules and the fact that all capsules are well-formed at 28 days, we think that &#x2013; akin to the resolution phase of wound healing (<xref ref-type="bibr" rid="B9">Darby et al., 2014</xref>; <xref ref-type="bibr" rid="B30">Hinz and Lagares, 2020</xref>) &#x2013; apoptosis is triggered earlier for the SIBS implants. Indeed, lack of sustained TGF-&#x3b2; secretion by macrophages could make fibroblasts sensitive to apoptosis (<xref ref-type="bibr" rid="B93">Zhang and Phan, 1999</xref>; <xref ref-type="bibr" rid="B42">Kulasekaran et al., 2009</xref>), which would also be induced by the continuous presence of inflammatory cytokines such as TNF-&#x3b1; (<xref ref-type="bibr" rid="B30">Hinz and Lagares, 2020</xref>; <xref ref-type="bibr" rid="B79">Wajant et al., 2003</xref>) around SIBS implants. As a whole, we speculate that the phase-separated surface morphology of SIBS may promote differential protein adsorption and consequent establishment of an inflammatory pro-apoptotic microenvironment that drives rapid resolution of the foreign body response around SIBS compared to PDMS. Consequently, protein adsorption studies and apoptosis assays are needed to test this hypothesis in the future, as other mechanisms &#x2013; involving T lymphocytes for example (<xref ref-type="bibr" rid="B13">Doloff et al., 2021</xref>; <xref ref-type="bibr" rid="B45">Lin et al., 2025</xref>; <xref ref-type="bibr" rid="B84">Yang et al., 2023</xref>) &#x2013; could very well be at play.</p>
</sec>
<sec id="s3-5">
<title>SIBS as a potential biomaterial alternative to PDMS</title>
<p>Considering the generalizable observation that SIBS is more biocompatible with a milder foreign body response, it becomes reasonable to think that its use as an alternative to PDMS could potentially reduce the complications of silicone-based implantable medical devices. Although this remains to be tested, SIBS might reduce the rates of capsular contracture with breast implants and mechanical obstruction of hydrocephalus shunts as well as help preserve residual acoustic hearing after cochlear implant surgery and extend the lifespan of subdermal contraceptive implants, which could perhaps ultimately reduce implant-related morbidity and associated healthcare costs.</p>
<p>Along with the conceivable benefit of a diminished foreign body response, the use of SIBS also presents other advantages and potential opportunities (<xref ref-type="table" rid="T3">Table 3</xref>). SIBS is hypothesized to be exceptionally resistant to oxidation, hydrolysis and enzymatic degradation (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>), and &#x2013; given that silicone-based implantable medical devices shed particles (<xref ref-type="bibr" rid="B12">Dijkman et al., 2021</xref>; <xref ref-type="bibr" rid="B11">de Bakker et al., 2023</xref>) &#x2013; it could potentially prevent the latter, further improving its biocompatibility. The remaining advantages of SIBS derive from its block copolymer nature, which confers to it better control of physicochemical properties and protein adsorption as well as thermo- and solution-forming capabilities. Indeed, its mechanical properties (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>; <xref ref-type="bibr" rid="B68">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Fittipaldi and Grace, 2017</xref>) and its protein adsorption dynamics (<xref ref-type="bibr" rid="B3">Bhushan and Schricker, 2014</xref>; <xref ref-type="bibr" rid="B18">Firkowska-Boden et al., 2018</xref>) can be tuned by altering the composition of its blocks. In addition, thermo-forming capacity enables injection and compression molding (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>) as well as 3D printing (<xref ref-type="bibr" rid="B68">Shen et al., 2021</xref>), while solution-forming makes solvent casting and bonding (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>) possible as well as dip (<xref ref-type="bibr" rid="B80">Wang et al., 2010</xref>) and spray coating (<xref ref-type="bibr" rid="B90">Yuan et al., 2016b</xref>). Besides these material processing advantages, SIBS can also be functionalized to carry sulfate (<xref ref-type="bibr" rid="B97">Zhu et al., 2012</xref>), nuclease (<xref ref-type="bibr" rid="B87">Yuan et al., 2014b</xref>), benzyl chloride (<xref ref-type="bibr" rid="B89">Yuan et al., 2016a</xref>), hyaluronic acid (<xref ref-type="bibr" rid="B86">Yuan et al., 2014a</xref>) or chitosan (<xref ref-type="bibr" rid="B86">Yuan et al., 2014a</xref>) groups as well as reinforced with carbon (<xref ref-type="bibr" rid="B60">Puskas et al., 2010</xref>; <xref ref-type="bibr" rid="B64">Rezvova et al., 2022</xref>) and infused with lubricating liquids (<xref ref-type="bibr" rid="B90">Yuan et al., 2016b</xref>; <xref ref-type="bibr" rid="B88">Yuan et al., 2015</xref>) to improve its hemocompatibility (<xref ref-type="bibr" rid="B90">Yuan et al., 2016b</xref>; <xref ref-type="bibr" rid="B97">Zhu et al., 2012</xref>; <xref ref-type="bibr" rid="B88">Yuan et al., 2015</xref>) and mechanical properties (<xref ref-type="bibr" rid="B64">Rezvova et al., 2022</xref>) as well as confer to it bactericidal (<xref ref-type="bibr" rid="B89">Yuan et al., 2016a</xref>; <xref ref-type="bibr" rid="B90">Yuan et al., 2016b</xref>; <xref ref-type="bibr" rid="B87">Yuan et al., 2014b</xref>; <xref ref-type="bibr" rid="B88">Yuan et al., 2015</xref>) and anti-fouling (<xref ref-type="bibr" rid="B86">Yuan et al., 2014a</xref>; <xref ref-type="bibr" rid="B90">Yuan et al., 2016b</xref>; <xref ref-type="bibr" rid="B88">Yuan et al., 2015</xref>) functions. That being said, silicone can also be modified to significantly improve its biocompatibility by casting it in texturized molds allowing surface roughness modulation (<xref ref-type="bibr" rid="B13">Doloff et al., 2021</xref>) as well as functionalizing it with collagen (<xref ref-type="bibr" rid="B50">Majd et al., 2015</xref>), human serum albumin (<xref ref-type="bibr" rid="B96">Zhou et al., 2024</xref>), interleukin-4 (<xref ref-type="bibr" rid="B41">Kim et al., 2021</xref>), dexamethasone (<xref ref-type="bibr" rid="B81">Wilk et al., 2016</xref>), pravastatin (<xref ref-type="bibr" rid="B44">Liao et al., 2019</xref>), the colony stimulating factor 1 receptor inhibitor (<xref ref-type="bibr" rid="B15">Farah et al., 2019</xref>) and the Met-Z2-Y12 antifibrotic agent (<xref ref-type="bibr" rid="B40">Karinja et al., 2023</xref>). In addition, zwitterionic coatings can also be used to drastically reduce the fibrous encapsulation of silicone with materials like poly (carboxybetaine methacrylate) (<xref ref-type="bibr" rid="B31">Horne et al., 2023</xref>), alginate-poly (ethylene imine) (<xref ref-type="bibr" rid="B94">Zhang et al., 2018</xref>) and methacryloyloxyethyl phosphorylcholine (<xref ref-type="bibr" rid="B85">Yesilyurt et al., 2017</xref>) polymers.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Advantages and disadvantages of SIBS as a potential biomaterial alternative to PDMS.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Criteria</th>
<th align="center">PDMS</th>
<th align="center">SIBS</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Biocompatibility including resistance to oxidation, hydrolysis and enzymatic degradation</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
</tr>
<tr>
<td align="left">Inherently tunable physicochemical properties as well as protein adsorption</td>
<td align="center">&#x2b;</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
</tr>
<tr>
<td align="left">Gas permeability enabling sterilization with ethylene oxide</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Thermo-formable allowing injection and compression molding as well as 3D printing</td>
<td align="center">-</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
</tr>
<tr>
<td align="left">Solution-formable enabling solvent casting and bonding as well as dip and spray coating</td>
<td align="center">-</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
</tr>
<tr>
<td align="left">Availability and affordability with respect to production</td>
<td align="center">&#x2b;&#x2b;&#x2b;</td>
<td align="center">&#x2b;</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Nevertheless, SIBS does have its limitations (<xref ref-type="table" rid="T3">Table 3</xref>). Compared to PDMS, it is not permeable to gas (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>), rendering ethylene oxide sterilization difficult, and is susceptible to oil absorption, which results in swelling (<xref ref-type="bibr" rid="B19">Fittipaldi and Grace, 2016</xref>) and brittleness (<xref ref-type="bibr" rid="B20">Fittipaldi and Grace, 2017</xref>). However, SIBS can also be chemically crosslinked at its hard glassy polystyrene blocks with 4-vinylbenzocyclobutene to prevent this (<xref ref-type="bibr" rid="B69">Sheriff et al., 2015</xref>). More importantly however, it is still much more expensive to produce SIBS (<xref ref-type="bibr" rid="B56">Pinchuk et al., 2008</xref>) compared to PDMS, which limits its availability and its further implementation as a biomaterial.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>Silicone-based implantable medical devices such as breast implants, hydrocephalus shunts and cochlear implants fail over time in approximately 10% of cases due to an excessive foreign body response to silicone. In this work, we evaluate the thermoplastic elastomer poly (styrene-<italic>block</italic>-isobutylene-<italic>block</italic>-styrene) (SIBS) as a potential alternative to polydimethylsiloxane (PDMS) by studying the foreign body response that they elicit. Although we demonstrate that both biomaterials have comparable physicochemical properties, we also observe that SIBS elicits a milder foreign body response characterized by the formation of a thinner, less cellular, fibrous capsule under the skin in mice. Our <italic>in vitro</italic> experiments show that macrophages display an altered phenotype on SIBS and produce conditioned media that reduces fibroblast contractility and enhances inflammatory gene expression. This leads us to hypothesize that the phase-separated surface morphology of SIBS, through differential protein adsorption, establishes an inflammatory pro-apoptotic microenvironment that accelerates the resolution of the foreign body response. Together, our results highlight SIBS as a promising biomaterial alternative to PDMS in hopes of reducing implant-related morbidity associated with silicone devices.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The studies involving humans were approved by McGill University Health Centre (MUHC) Research Ethics Board. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. The animal study was approved by Animal Care Committee of the Research Institute of the McGill University Health Centre (RI-MUHC). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>NK: Data curation, Investigation, Writing &#x2013; original draft, Writing &#x2013; review and editing, Conceptualization, Methodology, Visualization, Formal Analysis. LP: Writing &#x2013; review and editing, Resources. JV: Resources, Writing &#x2013; review and editing, Supervision, Conceptualization, Funding acquisition.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>Author LP is employed by Innovia, LLC. Author JV is a scientific advisor for Mentor at Johnson &#x0026; Johnson MedTech.</p>
<p>The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adusei</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Ngo</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Sadtler</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response</article-title>. <source>Acta Biomater.</source> <volume>133</volume>, <fpage>17</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2021.04.023</pub-id>
<pub-id pub-id-type="pmid">33905946</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>D. T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Foreign body reaction to biomaterials</article-title>. <source>Semin. Immunol.</source> <volume>20</volume>, <fpage>86</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2007.11.004</pub-id>
<pub-id pub-id-type="pmid">18162407</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhushan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schricker</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A review of block copolymer-based biomaterials that control protein and cell interactions</article-title>. <source>J. Biomed. Mater. Res. A</source> <volume>102</volume>, <fpage>2467</fpage>&#x2013;<lpage>2480</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.34887</pub-id>
<pub-id pub-id-type="pmid">23893878</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bigio</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>R</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology</article-title>. <source>Neurosurgery</source> <volume>42</volume>, <fpage>319</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1097/00006123-199802000-00064</pub-id>
<pub-id pub-id-type="pmid">9482182</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blakney</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Swartzlander</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The effects of substrate stiffness on the <italic>in vitro</italic> activation of macrophages and <italic>in vivo</italic> host response to poly(ethylene glycol)-based hydrogels</article-title>. <source>J. Biomed. Mater. Res. A</source> <volume>100</volume>, <fpage>1375</fpage>&#x2013;<lpage>1386</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.34104</pub-id>
<pub-id pub-id-type="pmid">22407522</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanput</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mes</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Wichers</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>THP-1 cell line: an <italic>in vitro</italic> cell model for immune modulation approach</article-title>. <source>Int. Immunopharmacol.</source> <volume>23</volume>, <fpage>37</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2014.08.002</pub-id>
<pub-id pub-id-type="pmid">25130606</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Effects of substrate topography on the regulation of human fibroblasts and capsule formation <italic>via</italic> modulating macrophage polarization</article-title>. <source>Colloids Surf. B Biointerfaces</source> <volume>222</volume>, <fpage>113086</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2022.113086</pub-id>
<pub-id pub-id-type="pmid">36542953</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Decoding the &#x201c;fingerprint&#x201d; of implant materials: insights into the foreign body reaction</article-title>. <source>Small</source> <volume>20</volume>, <fpage>2310325</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202310325</pub-id>
<pub-id pub-id-type="pmid">38191783</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darby</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Laverdet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bont&#xe9;</surname>
<given-names>F., A.</given-names>
</name>
<name>
<surname>Desmouli&#xe8;re</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Desmouli&#xe8;re, fibroblasts and myofibroblasts in wound healing</article-title>. <source>Clin. Cosmet. Investig. Dermatol.</source> <volume>7</volume>, <fpage>301</fpage>&#x2013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.2147/CCID.S50046</pub-id>
<pub-id pub-id-type="pmid">25395868</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davidson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kollias</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ludewig</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Turley</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Fibroblasts as immune regulators in infection, inflammation and cancer</article-title>. <source>Nat. Rev. Immunol.</source> <volume>21</volume>, <fpage>704</fpage>&#x2013;<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-021-00540-z</pub-id>
<pub-id pub-id-type="pmid">33911232</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Bakker</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zada</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>van Haasterecht</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vethaak</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Ariese</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Baker grade IV capsular contracture is correlated with an increased amount of silicone material: an intrapatient study</article-title>. <source>Plast. Reconstr. Surg.</source> <volume>152</volume>, <fpage>1191</fpage>&#x2013;<lpage>1200</lpage>. <pub-id pub-id-type="doi">10.1097/PRS.0000000000010359</pub-id>
<pub-id pub-id-type="pmid">36877628</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dijkman</surname>
<given-names>H. B. P. M.</given-names>
</name>
<name>
<surname>Slaats</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bult</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Assessment of silicone particle migration among women undergoing removal or revision of silicone breast implants in the Netherlands</article-title>. <source>JAMA Netw. Open</source> <volume>4</volume>, <fpage>e2125381</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.25381</pub-id>
<pub-id pub-id-type="pmid">34542618</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doloff</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Veiseh</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>de Mezerville</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sforza</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Haupt</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits and humans</article-title>. <source>Nat. Biomed. Eng.</source> <volume>5</volume>, <fpage>1115</fpage>&#x2013;<lpage>1130</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-021-00739-4</pub-id>
<pub-id pub-id-type="pmid">34155355</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Kalashnikov</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Robust and precise wounding and analysis of engineered contractile tissues</article-title>. <source>Tissue Eng. Part C Methods</source> <volume>25</volume>, <fpage>677</fpage>&#x2013;<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2019.0123</pub-id>
<pub-id pub-id-type="pmid">31411125</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Doloff</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sadraei</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Olafson</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations</article-title>. <source>Nat. Mater.</source> <volume>18</volume>, <fpage>892</fpage>&#x2013;<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1038/s41563-019-0377-5</pub-id>
<pub-id pub-id-type="pmid">31235902</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fayzullin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bakulina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mikaelyan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shekhter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guller</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Implantable drug delivery systems and foreign body reaction: traversing the current clinical landscape</article-title>. <source>Bioengineering</source> <volume>8</volume>, <fpage>205</fpage>. <pub-id pub-id-type="doi">10.3390/bioengineering8120205</pub-id>
<pub-id pub-id-type="pmid">34940358</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finnson</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Guglielmo</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Philip</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Dynamics of transforming growth factor beta signaling in wound healing and scarring</article-title>. <source>Adv. Wound Care</source> <volume>2</volume>, <fpage>195</fpage>&#x2013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2013.0429</pub-id>
<pub-id pub-id-type="pmid">24527343</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firkowska-Boden</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jandt</surname>
<given-names>K. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Controlling protein adsorption through nanostructured polymeric surfaces</article-title>. <source>Adv. Healthc. Mater.</source> <volume>7</volume>. <pub-id pub-id-type="doi">10.1002/adhm.201700995</pub-id>
<pub-id pub-id-type="pmid">29193909</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fittipaldi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>L. R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Lipid diffusion and swelling in a phase separated biocompatible thermoplastic elastomer</article-title>. <source>J. Mech. Behav. Biomed. Mater.</source> <volume>64</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmbbm.2016.07.016</pub-id>
<pub-id pub-id-type="pmid">27479889</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fittipaldi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>L. R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Lipid-induced degradation in biocompatible poly(Styrene-Isobutylene-Styrene) (SIBS) thermoplastic elastomer</article-title>. <source>J. Mech. Behav. Biomed. Mater.</source> <volume>68</volume>, <fpage>80</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmbbm.2017.01.031</pub-id>
<pub-id pub-id-type="pmid">28157597</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foggia</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Quevedo</surname>
<given-names>R. V.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Intracochlear fibrosis and the foreign body response to cochlear implant biomaterials</article-title>. <source>Laryngoscope Investig. Otolaryngol.</source> <volume>4</volume>, <fpage>678</fpage>&#x2013;<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1002/lio2.329</pub-id>
<pub-id pub-id-type="pmid">31890888</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foroushani</surname>
<given-names>F. T.</given-names>
</name>
<name>
<surname>Dzobo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Khumalo</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Mora</surname>
<given-names>V. Z.</given-names>
</name>
<name>
<surname>de Mezerville</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bayat</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Advances in surface modifications of the silicone breast implant and impact on its biocompatibility and biointegration</article-title>. <source>Biomater. Res.</source> <volume>26</volume>, <fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/s40824-022-00314-1</pub-id>
<pub-id pub-id-type="pmid">36517896</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghazarian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garner</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Memory of past exposure to the chemokine IL-8 inhibits the contraction of fibroblast-populated collagen lattices</article-title>. <source>Exp. Mol. Pathol.</source> <volume>69</volume>, <fpage>242</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1006/exmp.2000.2329</pub-id>
<pub-id pub-id-type="pmid">11115365</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldberg</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.-P.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Garner</surname>
<given-names>W. L.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>TNF-<italic>&#x3b1;</italic> suppresses <italic>&#x3b1;</italic>-Smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing</article-title>. <source>J. Invest. Dermatol.</source> <volume>127</volume>, <fpage>2645</fpage>&#x2013;<lpage>2655</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jid.5700890</pub-id>
<pub-id pub-id-type="pmid">17554369</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorgy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barone</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nepon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dalfen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Efanov</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Davison</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Implant-based breast surgery and capsular formation: when, how and why? a narrative review</article-title>. <source>Ann. Transl. Med.</source> <volume>11</volume>, <fpage>385</fpage>. <pub-id pub-id-type="doi">10.21037/atm-23-131</pub-id>
<pub-id pub-id-type="pmid">37970601</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goswami</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Arya</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Stamov</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mechanosensing by TRPV4 mediates stiffness-induced foreign body response and giant cell formation</article-title>. <source>Sci. Signal.</source> <volume>14</volume>, <fpage>eabd4077</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.abd4077</pub-id>
<pub-id pub-id-type="pmid">34726952</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>J. P. I.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>What we should know about the cellular and tissue response causing catheter obstruction in the treatment of hydrocephalus</article-title>. <source>Neurosurgery</source> <volume>70</volume>, <fpage>1589</fpage>&#x2013;<lpage>1601</lpage>. <pub-id pub-id-type="doi">10.1227/NEU.0b013e318244695f</pub-id>
<pub-id pub-id-type="pmid">22157548</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Blakney</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H. V.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>B. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants</article-title>. <source>Biomaterials</source> <volume>273</volume>, <fpage>120806</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.120806</pub-id>
<pub-id pub-id-type="pmid">33905960</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Gerry</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Walkowiak</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Kavarana</surname>
<given-names>M. N.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Immune privilege of heart valves</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>731361</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.731361</pub-id>
<pub-id pub-id-type="pmid">34447390</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lagares</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases</article-title>. <source>Nat. Rev. Rheumatol.</source> <volume>16</volume>, <fpage>11</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/s41584-019-0324-5</pub-id>
<pub-id pub-id-type="pmid">31792399</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horne</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ben-Shlomo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ellerman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Escudero</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Reducing the foreign body response on human cochlear implants and their materials <italic>in vivo</italic> with photografted zwitterionic hydrogel coatings</article-title>. <source>Acta Biomater.</source> <volume>166</volume>, <fpage>212</fpage>&#x2013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2023.05.011</pub-id>
<pub-id pub-id-type="pmid">37187301</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hotchkiss</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Hyzy</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Boyan</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Olivares-Navarrete</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Titanium surface characteristics, including topography and wettability, alter macrophage activation</article-title>. <source>Acta Biomater.</source> <volume>31</volume>, <fpage>425</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2015.12.003</pub-id>
<pub-id pub-id-type="pmid">26675126</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iocono</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Colleran</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Remick</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Garner</surname>
<given-names>W. L.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Interleukin-8 levels and activity in delayed-healing human thermal wounds</article-title>. <source>Wound Repair Regen.</source> <volume>8</volume>, <fpage>216</fpage>&#x2013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1046/j.1524-475x.2000.00216.x</pub-id>
<pub-id pub-id-type="pmid">10886812</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansen</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Amer</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E.Y.-T.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Saleh</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Emrick</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Zwitterionic PEG-PC hydrogels modulate the foreign body response in a modulus-dependent manner</article-title>. <source>Biomacromolecules</source> <volume>19</volume>, <fpage>2880</fpage>&#x2013;<lpage>2888</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.8b00444</pub-id>
<pub-id pub-id-type="pmid">29698603</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalashnikov</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Morphodynamic tissues <italic>via</italic> integrated programmable shape memory actuators</article-title>. <source>Adv. Funct. Mater.</source> <volume>29</volume>, <fpage>1903327</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.201903327</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalashnikov</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Engineering physical microenvironments to study innate immune cell biophysics</article-title>. <source>Apl. Bioeng.</source> <volume>6</volume>, <fpage>031504</fpage>. <pub-id pub-id-type="doi">10.1063/5.0098578</pub-id>
<pub-id pub-id-type="pmid">36156981</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalashnikov</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Substrate viscoelasticity affects human macrophage morphology and phagocytosis</article-title>. <source>Soft Matter</source> <volume>19</volume>, <fpage>2438</fpage>&#x2013;<lpage>2445</lpage>. <pub-id pub-id-type="doi">10.1039/D2SM01683D</pub-id>
<pub-id pub-id-type="pmid">36930245</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalashnikov</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Barralet</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vorstenbosch</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Implantable medical devices, biomaterials, and the foreign body response: a surgical perspective</article-title>. <source>J. Biomed. Mater. Res. A</source> <volume>113</volume>, <fpage>e37983</fpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.37983</pub-id>
<pub-id pub-id-type="pmid">40899623</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The Taxus<sup>TM</sup> drug-eluting stent: a new paradigm in controlled drug delivery</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>58</volume>, <fpage>412</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2006.01.023</pub-id>
<pub-id pub-id-type="pmid">16647782</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karinja</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abadeer</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>An antifibrotic breast implant surface coating significantly reduces periprosthetic capsule formation</article-title>. <source>Plast. Reconstr. Surg.</source> <volume>152</volume>, <fpage>775</fpage>&#x2013;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1097/PRS.0000000000010323</pub-id>
<pub-id pub-id-type="pmid">36847657</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.-S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>B.-H.</given-names>
</name>
<name>
<surname>Heo</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Faruq</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Van Anh</surname>
<given-names>L. T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Silicone implants immobilized with Interleukin-4 promote the M2 polarization of macrophages and inhibit the formation of fibrous capsules</article-title>. <source>Polymers</source> <volume>13</volume>, <fpage>2630</fpage>. <pub-id pub-id-type="doi">10.3390/polym13162630</pub-id>
<pub-id pub-id-type="pmid">34451169</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulasekaran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Scavone</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Arenberg</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Thannickal</surname>
<given-names>V. J.</given-names>
</name>
<name>
<surname>Horowitz</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Endothelin-1 and transforming growth Factor-&#x3b2;1 independently induce fibroblast resistance to apoptosis <italic>via</italic> AKT activation</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>41</volume>, <fpage>484</fpage>&#x2013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2008-0447OC</pub-id>
<pub-id pub-id-type="pmid">19188658</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Sanjabi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>A.-K. L.</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Transforming growth factor-&#x3b2; regulation of immune responses</article-title>. <source>Annu. Rev. Immunol.</source> <volume>24</volume>, <fpage>99</fpage>&#x2013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.24.021605.090737</pub-id>
<pub-id pub-id-type="pmid">16551245</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Pravastatin regulates host foreign-body reaction to polyetheretherketone implants <italic>via</italic> miR-29ab1-mediated SLIT3 upregulation</article-title>. <source>Biomaterials</source> <volume>203</volume>, <fpage>12</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.02.027</pub-id>
<pub-id pub-id-type="pmid">30851489</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Systemic T-cell and local macrophage interactions mediate granule size-dependent biological hydroxyapatite foreign body reaction</article-title>. <source>BMEMat</source> <volume>3</volume>, <fpage>e12133</fpage>. <pub-id pub-id-type="doi">10.1002/bmm2.12133</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Segura</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Biomaterials-mediated regulation of macrophage cell fate</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>8</volume>, <fpage>609297</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.609297</pub-id>
<pub-id pub-id-type="pmid">33363135</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>T. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT method</article-title>. <source>Methods</source> <volume>25</volume>, <fpage>402</fpage>&#x2013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
<pub-id pub-id-type="pmid">11846609</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lund</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>To</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus</article-title>. <source>J. Immunol. Methods</source> <volume>430</volume>, <fpage>64</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.jim.2016.01.012</pub-id>
<pub-id pub-id-type="pmid">26826276</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Unveiling the mechanism of surface hydrophilicity-modulated macrophage polarization</article-title>. <source>Adv. Healthc. Mater.</source> <volume>7</volume>, <fpage>1800675</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201800675</pub-id>
<pub-id pub-id-type="pmid">30106513</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majd</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Boo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramondetti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cambridge</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Raffoul</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Novel micropatterns mechanically control fibrotic reactions at the surface of silicone implants</article-title>. <source>Biomaterials</source> <volume>54</volume>, <fpage>136</fpage>&#x2013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.03.027</pub-id>
<pub-id pub-id-type="pmid">25907047</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shimazaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Tissue reactivity to, and stability of, glaucoma drainage device materials placed under rabbit conjunctiva</article-title>. <source>Transl. Vis. Sci. Technol.</source> <volume>11</volume>, <fpage>9</fpage>. <pub-id pub-id-type="doi">10.1167/tvst.11.4.9</pub-id>
<pub-id pub-id-type="pmid">35404438</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niederkorn</surname>
<given-names>J. Y.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>See no evil, hear no evil, do no evil: the lessons of immune privilege</article-title>. <source>Nat. Immunol.</source> <volume>7</volume>, <fpage>354</fpage>&#x2013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1038/ni1328</pub-id>
<pub-id pub-id-type="pmid">16550198</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noskovicova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pakshir</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Implant fibrosis and the underappreciated role of myofibroblasts in the foreign body reaction</article-title>. <source>Cells</source> <volume>10</volume>, <fpage>1794</fpage>. <pub-id pub-id-type="doi">10.3390/cells10071794</pub-id>
<pub-id pub-id-type="pmid">34359963</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noskovicova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schuster</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Putten</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ezzo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koehler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boo</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Suppression of the fibrotic encapsulation of silicone implants by inhibiting the mechanical activation of pro-fibrotic TGF-&#x3b2;</article-title>. <source>Nat. Biomed. Eng.</source> <volume>5</volume>, <fpage>1437</fpage>&#x2013;<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-021-00722-z</pub-id>
<pub-id pub-id-type="pmid">34031559</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ovcharenko</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rezvova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nikishau</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kostjuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Glushkova</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Antonova</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Polyisobutylene-based thermoplastic elastomers for manufacturing polymeric heart valve leaflets: <italic>in vitro</italic> and <italic>in vivo</italic> results</article-title>. <source>Appl. Sci.</source> <volume>9</volume>, <fpage>4773</fpage>. <pub-id pub-id-type="doi">10.3390/app9224773</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinchuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Schoephoerster</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Parel</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Medical applications of poly(styrene-block-isobutylene-block-styrene) (&#x201c;SIBS&#x201d;)</article-title>. <source>Biomaterials</source> <volume>29</volume>, <fpage>448</fpage>&#x2013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.09.041</pub-id>
<pub-id pub-id-type="pmid">17980425</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinchuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Riss</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Batlle</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Arrieta</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The use of poly(styrene-block -isobutylene- block -styrene) as a microshunt to treat glaucoma</article-title>. <source>Regen. Biomater.</source> <volume>3</volume>, <fpage>137</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1093/rb/rbw005</pub-id>
<pub-id pub-id-type="pmid">27047682</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinchuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Riss</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Batlle</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Arrieta</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma</article-title>. <source>J. Biomed. Mater. Res. B Appl. Biomater.</source> <volume>105</volume>, <fpage>211</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.33525</pub-id>
<pub-id pub-id-type="pmid">26380916</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Previtera</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Substrate stiffness regulates proinflammatory mediator production through TLR4 activity in macrophages</article-title>. <source>PLOS ONE</source> <volume>10</volume>, <fpage>e0145813</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0145813</pub-id>
<pub-id pub-id-type="pmid">26710072</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puskas</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Foreman-Orlowski</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>G. T.</given-names>
</name>
<name>
<surname>Porosky</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Evancho-Chapman</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S. P.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>A nanostructured carbon-reinforced polyisobutylene-based thermoplastic elastomer</article-title>. <source>Biomaterials</source> <volume>31</volume>, <fpage>2477</fpage>&#x2013;<lpage>2488</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.12.003</pub-id>
<pub-id pub-id-type="pmid">20034664</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Courtney</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Silicones as biomaterials</article-title>. <source>Br. Polym. J.</source> <volume>20</volume>, <fpage>25</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/pi.4980200106</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mozafari</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Protein adsorption on polymers</article-title>. <source>Mater. Today Commun.</source> <volume>17</volume>, <fpage>527</fpage>&#x2013;<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1016/j.mtcomm.2018.10.024</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ranade</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Helmus</surname>
<given-names>M. N.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Styrenic block copolymers for biomaterial and drug delivery applications</article-title>. <source>Acta Biomater.</source> <volume>1</volume>, <fpage>137</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2004.09.004</pub-id>
<pub-id pub-id-type="pmid">16701787</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvova</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Nikishau</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Makarevich</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Glushkova</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Klyshnikov</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Akentieva</surname>
<given-names>T. N.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Biomaterials based on carbon nanotube nanocomposites of Poly(styrene-b-isobutylene-b-styrene): the effect of nanotube content on the mechanical properties, biocompatibility and hemocompatibility</article-title>. <source>Nanomaterials</source> <volume>12</volume>, <fpage>733</fpage>. <pub-id pub-id-type="doi">10.3390/nano12050733</pub-id>
<pub-id pub-id-type="pmid">35269222</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuster</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rockel</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Kapoor</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The inflammatory speech of fibroblasts</article-title>. <source>Immunol. Rev.</source> <volume>302</volume>, <fpage>126</fpage>&#x2013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12971</pub-id>
<pub-id pub-id-type="pmid">33987902</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seghir</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Arscott</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Extended PDMS stiffness range for flexible systems</article-title>. <source>Sens. Actuators Phys.</source> <volume>230</volume>, <fpage>33</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.sna.2015.04.011</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheikh</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Barzilay</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fine</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Glogauer</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Macrophages, foreign body giant cells and their response to implantable biomaterials</article-title>. <source>Materials</source> <volume>8</volume>, <fpage>5671</fpage>&#x2013;<lpage>5701</lpage>. <pub-id pub-id-type="doi">10.3390/ma8095269</pub-id>
<pub-id pub-id-type="pmid">28793529</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kasbe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Khabaz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Macromolecular engineering and additive manufacturing of Poly(styrene-b-isobutylene-b-styrene)</article-title>. <source>ACS Appl. Polym. Mater.</source> <volume>3</volume>, <fpage>4554</fpage>&#x2013;<lpage>4562</lpage>. <pub-id pub-id-type="doi">10.1021/acsapm.1c00616</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheriff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Claiborne</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Kothadia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>Y. P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Physical characterization and platelet interactions under shear flows of a novel thermoset polyisobutylene-based Co-polymer</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>7</volume>, <fpage>22058</fpage>&#x2013;<lpage>22066</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.5b07254</pub-id>
<pub-id pub-id-type="pmid">26398588</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Choy</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Heo</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Silicone breast implant modification review: overcoming capsular contracture</article-title>. <source>Biomater. Res.</source> <volume>22</volume>, <fpage>37</fpage>. <pub-id pub-id-type="doi">10.1186/s40824-018-0147-5</pub-id>
<pub-id pub-id-type="pmid">30598837</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sridharan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cavanagh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cameron</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname>
<given-names>F. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Material stiffness influences the polarization state, function and migration mode of macrophages</article-title>. <source>Acta Biomater.</source> <volume>89</volume>, <fpage>47</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2019.02.048</pub-id>
<pub-id pub-id-type="pmid">30826478</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stone</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Hermiller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O&#x2019;Shaughnessy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J. T.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease</article-title>. <source>N. Engl. J. Med.</source> <volume>350</volume>, <fpage>221</fpage>&#x2013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa032441</pub-id>
<pub-id pub-id-type="pmid">14724301</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Streilein</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Ocular immune privilege: therapeutic opportunities from an experiment of nature</article-title>. <source>Nat. Rev. Immunol.</source> <volume>3</volume>, <fpage>879</fpage>&#x2013;<lpage>889</lpage>. <pub-id pub-id-type="doi">10.1038/nri1224</pub-id>
<pub-id pub-id-type="pmid">14668804</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Nadeau</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abbasi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lachance</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fenrich</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The ultimate qPCR experiment: producing publication quality, reproducible data the first time</article-title>. <source>Trends Biotechnol.</source> <volume>37</volume>, <fpage>761</fpage>&#x2013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2018.12.002</pub-id>
<pub-id pub-id-type="pmid">30654913</pub-id>
</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tedesco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Majo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trenti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trevisi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fadini</surname>
<given-names>G. P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Convenience <italic>versus</italic> biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying <italic>in vitro</italic> polarization?</article-title> <source>Front. Pharmacol.</source> <volume>9</volume>, <fpage>71</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00071</pub-id>
<pub-id pub-id-type="pmid">29520230</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tellides</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pober</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Inflammatory and immune responses in the arterial media</article-title>. <source>Circ. Res.</source> <volume>116</volume>, <fpage>312</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.301312</pub-id>
<pub-id pub-id-type="pmid">25593276</pub-id>
</mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vassey</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Figueredo</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Scurr</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Vasilevich</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carlier</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Immune modulation by design: using topography to control human monocyte attachment and macrophage differentiation</article-title>. <source>Adv. Sci.</source> <volume>7</volume>, <fpage>1903392</fpage>. <pub-id pub-id-type="doi">10.1002/advs.201903392</pub-id>
<pub-id pub-id-type="pmid">32537404</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visalakshan</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>MacGregor</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Sasidharan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghazaryan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mierczynska-Vasilev</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Morsbach</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Biomaterial surface hydrophobicity-mediated serum protein adsorption and immune responses</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>11</volume>, <fpage>27615</fpage>&#x2013;<lpage>27623</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b09900</pub-id>
<pub-id pub-id-type="pmid">31310498</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wajant</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pfizenmaier</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Scheurich</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Tumor necrosis factor signaling</article-title>. <source>Cell Death Differ.</source> <volume>10</volume>, <fpage>45</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401189</pub-id>
<pub-id pub-id-type="pmid">12655295</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>McGoron</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Pinchuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schoephoerster</surname>
<given-names>R. T.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A novel small animal model for biocompatibility assessment of polymeric materials for use in prosthetic heart valves</article-title>. <source>J. Biomed. Mater. Res. A</source> <volume>93A</volume>, <fpage>442</fpage>&#x2013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.32562</pub-id>
<pub-id pub-id-type="pmid">19569223</pub-id>
</mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hessler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mugridge</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jolly</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fehr</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lenarz</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Impedance changes and fibrous tissue growth after cochlear implantation are correlated and can be reduced using a dexamethasone eluting electrode</article-title>. <source>PLOS ONE</source> <volume>11</volume>, <fpage>e0147552</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0147552</pub-id>
<pub-id pub-id-type="pmid">26840740</pub-id>
</mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witherel</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Abebayehu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Spiller</surname>
<given-names>K. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Macrophage and fibroblast interactions in biomaterial-mediated fibrosis</article-title>. <source>Adv. Healthc. Mater.</source> <volume>8</volume>, <fpage>1801451</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201801451</pub-id>
<pub-id pub-id-type="pmid">30658015</pub-id>
</mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yampolsky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bachelet</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Reproducible strategy for excisional skin-wound-healing studies in mice</article-title>. <source>Nat. Protoc.</source> <volume>19</volume>, <fpage>184</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1038/s41596-023-00899-4</pub-id>
<pub-id pub-id-type="pmid">38030941</pub-id>
</mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rutkowski</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Elisseeff</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The foreign body response: emerging cell types and considerations for targeted therapeutics</article-title>. <source>Biomater. Sci.</source> <volume>11</volume>, <fpage>7730</fpage>&#x2013;<lpage>7747</lpage>. <pub-id pub-id-type="doi">10.1039/D3BM00629H</pub-id>
<pub-id pub-id-type="pmid">37904536</pub-id>
</mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yesilyurt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Veiseh</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Doloff</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A facile and versatile method to endow biomaterial devices with zwitterionic surface coatings</article-title>. <source>Adv. Healthc. Mater.</source> <volume>6</volume>. <pub-id pub-id-type="doi">10.1002/adhm.201601091</pub-id>
<pub-id pub-id-type="pmid">27976536</pub-id>
</mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2014a</year>). <article-title>Enhanced biocompatibility of biostable poly(styrene-b -isobutylene- b -styrene) elastomer <italic>via</italic> poly(dopamine)-assisted chitosan/hyaluronic acid immobilization</article-title>. <source>RSC Adv.</source> <volume>4</volume>, <fpage>31481</fpage>&#x2013;<lpage>31488</lpage>. <pub-id pub-id-type="doi">10.1039/C4RA04523H</pub-id>
</mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2014b</year>). <article-title>Nuclease-functionalized Poly(Styrene-b-isobutylene-b-styrene) surface with anti-infection and tissue integration bifunctions</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>6</volume>, <fpage>18078</fpage>&#x2013;<lpage>18086</lpage>. <pub-id pub-id-type="doi">10.1021/am504955g</pub-id>
<pub-id pub-id-type="pmid">25253647</pub-id>
</mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Facile fabrication of lubricant-infused wrinkling surface for preventing thrombus formation and infection</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>7</volume>, <fpage>19466</fpage>&#x2013;<lpage>19473</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.5b05865</pub-id>
<pub-id pub-id-type="pmid">26268298</pub-id>
</mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016a</year>). <article-title>Infection-resistant styrenic thermoplastic elastomers that can switch from bactericidal capability to anti-adhesion</article-title>. <source>J. Mater. Chem. B</source> <volume>4</volume>, <fpage>1081</fpage>&#x2013;<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1039/C5TB02138C</pub-id>
<pub-id pub-id-type="pmid">32263000</pub-id>
</mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016b</year>). <article-title>Liquid-infused Poly(styrene-b-isobutylene-b-styrene) microfiber coating prevents bacterial attachment and thrombosis</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>8</volume>, <fpage>21214</fpage>&#x2013;<lpage>21220</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.6b06407</pub-id>
<pub-id pub-id-type="pmid">27482919</pub-id>
</mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zare</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ghomi</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Venkatraman</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Ramakrishna</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Silicone-based biomaterials for biomedical applications: antimicrobial strategies and 3D printing technologies</article-title>. <source>J. Appl. Polym. Sci.</source> <volume>138</volume>, <fpage>50969</fpage>. <pub-id pub-id-type="doi">10.1002/app.50969</pub-id>
</mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Changes in the proteomic profile during the differential polarization status of the human monocyte-derived macrophage THP-1 cell line</article-title>. <source>PROTEOMICS</source> <volume>15</volume>, <fpage>773</fpage>&#x2013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201300494</pub-id>
<pub-id pub-id-type="pmid">25411139</pub-id>
</mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Inhibition of myofibroblast apoptosis by transforming growth factor &#x3b2;1</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>21</volume>, <fpage>658</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.21.6.3720</pub-id>
<pub-id pub-id-type="pmid">10572062</pub-id>
</mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Novel balanced charged Alginate/PEI polyelectrolyte hydrogel that resists foreign-body reaction</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>10</volume>, <fpage>6879</fpage>&#x2013;<lpage>6886</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.7b17670</pub-id>
<pub-id pub-id-type="pmid">29393622</pub-id>
</mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Dealing with the foreign-body response to implanted biomaterials: strategies and applications of new materials</article-title>. <source>Adv. Funct. Mater.</source> <volume>31</volume>, <fpage>2007226</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.202007226</pub-id>
</mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Peng Zhang, covalently grafted human serum albumin coating mitigates the foreign body response against silicone implants in mice</article-title>. <source>Bioact. Mater.</source> <volume>34</volume>, <fpage>482</fpage>&#x2013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2024.01.006</pub-id>
<pub-id pub-id-type="pmid">38292409</pub-id>
</mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>J.-Z.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X.-W.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.-M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Hemocompatibility of drug-eluting coronary stents coated with sulfonated poly (styrene-block-isobutylene-block-styrene)</article-title>. <source>Biomaterials</source> <volume>33</volume>, <fpage>8204</fpage>&#x2013;<lpage>8212</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.07.066</pub-id>
<pub-id pub-id-type="pmid">22898183</pub-id>
</mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Mustafa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Connell</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Grande-Allen</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Tumor necrosis factor alpha and interleukin 1 beta suppress myofibroblast activation <italic>via</italic> nuclear factor kappa B signaling in 3D-cultured mitral valve interstitial cells</article-title>. <source>Acta Biomater.</source> <volume>127</volume>, <fpage>159</fpage>&#x2013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2021.03.075</pub-id>
<pub-id pub-id-type="pmid">33831572</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1438819/overview">Sangram Keshari Samal</ext-link>, Regional Medical Research Center (ICMR), India</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1499125/overview">Dongli Fan</ext-link>, Army Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2047529/overview">Liqiang Zhou</ext-link>, University of Macau, China</p>
</fn>
</fn-group>
</back>
</article>